Stocks · News reference
Ingevity Raises FY2026 Adj EPS Guidance from $4.70-$5.20 to $5.00-$5.45 vs $5.01 Est; Affirms FY2026 Sales Guidance of $1.050B-$1.150B vs $1.109B Est
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Ingevity Corp (NGVT)
Filed: 2026-07-29 AccNo: 0001653477-26-000044 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Ingevity’s Evotherm P35 Secures BASt Approval For Warm‑Mix Asphalt In Germany
Approval reflects alignment with evolving regulatory and performance standard for German market requirementsIngevity Corporation (NYSE:NGVT) today announced Evotherm® P35 warm-mix additive has received approval from